[REVIDAL-GERDA: organization and collaboration with pharmacovigilance].
Vigan
M
M
Service de Dermatologie 2, Hôpital Saint-Jacques, Besançon, France. vigan@ufc-chu.univ-fcomte.fr
D003875:Drug Eruptions / Q000453:epidemiology*; D006801:Humans; D011358:Product Surveillance, Postmarketing / Q000639:trends*; D012957:Societies, Pharmaceutical